Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia

NCT00488020 is registered in ClinicalTrials.gov with Instituto de Molestias Cardiovasculares as lead sponsor.

NCT NCT00488020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00488020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia
Lead sponsor
Instituto de Molestias Cardiovasculares
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2006
Completion date
June 30, 2007
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, ischemic ulcers